Skip to main content
. 2021 Apr 2;19(4):e3000959. doi: 10.1371/journal.pbio.3000959

Table 5. Top 10 most blogged COVID-19 preprints.

Rank Source DOI Title Posted date Tweets News articles Blogs
1 medRxiv 10.1101/2020.04.14.20062463 COVID-19 Antibody Seroprevalence in Santa Clara County, California April 17, 2020 26,763 434 55
2 medRxiv 10.1101/2020.04.04.20053058 Indoor transmission of SARS-CoV-2 April 7, 2020 21,831 187 34
3 bioRxiv 10.1101/2020.04.29.069054 Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2 April 30, 2020 6,848 449 29
4 medRxiv 10.1101/2020.03.09.20033217 Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 March 10, 2020 12,484 354 29
5 medRxiv 10.1101/2020.04.16.20065920 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 April 21, 2020 10,385 411 27
6 medRxiv 10.1101/2020.07.09.20148429 Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection July 11, 2020 2,167 281 27
7 medRxiv 10.1101/2020.06.22.20137273 Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report June 22, 2020 5,698 246 26
8 medRxiv 10.1101/2020.08.12.20169359 Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience August 12, 2020 2,746 264 26
9 bioRxiv 10.1101/2020.01.30.927871 Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag January 31, 2020 16,608 102 25
10 bioRxiv 10.1101/2020.03.30.015347 Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2 March 31, 2020 4,168 209 25
11 medRxiv 10.1101/2020.10.15.20209817 Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results October 15, 2020 8,569 396 25

COVID-19, Coronavirus Disease 2019.